Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 6, 2010, Pages 1795-1800

  Firdous, Alikunjhi P ^a   Sindhu, Edakkadath R ^a   Ramnath, Viswanathan ^b   Kuttan, Ramadasan ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

^b Kerala Veterinary and Animal Sciences University   (India)

Author keywords

Anticarcinogenicity; Antimutagenicity; Carotenoid; CYP450 enzymes; Meso zeaxanthin

Indexed keywords

EID: 79956157026     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Anna CH, Maronpot RR, Pereira MA, et al (1994). Ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene-, and tetra chloro ethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis, 15, 2255-61.
2. Boiter E, Merad-Boudia M, Guguen-Guillouzo C, et al (1995). Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine induced rat hepatomas: possible involvement of free radical. Cancer Res, 55, 3028-35.
3. Chang GJ (2006). Thirteen week oral (gavage) toxicity of meso-Zeaxanthin in Hans wistar rats with a four-week recovery. Howard foundation. Gene logic laboratories inc. Study no.1567 - 04370.
4. Firdous AP, Preethi KC, Kuttan R (2010). Antioxidant potential of meso-Zeaxanthin a semi synthetic carotenoid. Food chem, 119, 1096.
5. Froment O, Boivin S, Barbin A, et al (1994). Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Cancer Res, 54, 5340-5.
6. Garner RC, Miller EC, Miller JA (1972). Liver microsomal metabolism of aflatoxin B1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res, 32, 2058-66.
7. Jose JK, Joy KL, Kuttan R (1999). Effect of emblica officinalis, phyllanthus amarus and picrorrhiza on NDEA induced hepatocellular carcinogenesis. Cancer letters, 135, 1-6.
8. Krinski NI (1993). Action of carotenoids in biological systems. Ann Rev Nutr, Palo Alto, 13, 561-87.
9. Krinsky NI (1989). Antioxidant functions of carotenoids. Free Radical Biol Med, 7, 617-35.
10. Maoka T, Arai A, Shimizu M, Mastsuno T (1986). The first isolation of enantiomaric meso-Zeaxanthin in nature. Comp Biochem Physiol B, 83, 121-4.
11. Mazel P (1971). Fundamentals of Drug Metabolism and Drug Disposition,ed.by La Duq B. N, Mandel H. G, Way E. L,Williams & Wilkins, Baltimore, 546-78.
12. Moron DM and Ames BN (1983). Revised methods for salmonella mutagenicity test. Mutat Res, 113, 173-215.
13. Nerurkar PV, Park SS, Thomas PE, et al (1993). Proc Am Assoc Cancer Res, 34, 931.
14. Oliff A, Gibbs JB, McCormick F (1996). New molecular targets for cancer therapy. Sci Am, 275, 110-5.
15. Pohl RJ, Fouts JR (1980). Anal Biochem, 107, 150-5. Sukumaran K, Kuttan R (1995). Inhibition of tobacco-induced mutagenesis by eugenol and plant extracts. Mutat Res, 343, 25-30.
16. Telliez JB, Plumb M, Balmain A, Bailleul B (1995). Regulatory elements in the first intron of the mouse Ha-ras gene. Mol Carcinog, 12, 137-45.
17. Thurnham DI (2007). Macular zeaxanthins and lutein - a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease. Nutr Res Rev, 20, 163-79.